Kiniksa PharmaceuticalsKNSA
那斯達克 · USD
41.83
+0.80
(+1.95%)
收盤 01/22 04:59 (UTC+8)
01/22 04:59 (UTC+8)
Kiniksa PharmaceuticalsKNSA
41.83
+0.80
(+1.95%)
財務數據
損益表
- 0.71
- 0.67
- 0.83
- 0.80
- 1.09
- 1.12
- 1.23
- 1.38
- 1.57
- 1.81
- 47.84
- -6.19
- 24.38
- -4.24
- 36.03
- 3.30
- 9.20
- 12.44
- 13.80
- 15.34
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 180,855 | 156,797 | 137,785 | 122,536 | 112,214 | 108,631 | 79,858 | 83,395 | 67,046 | 71,473 |
營業成本 | 20,257 | 18,603 | 17,868 | 17,896 | 20,109 | 12,322 | 10,583 | 9,584 | 9,088 | 7,699 |
營業毛利 | 160,598 | 138,194 | 119,917 | 104,640 | 92,105 | 96,309 | 69,275 | 73,811 | 57,958 | 63,774 |
營業費用 | 136,577 | 118,034 | - | 123,939 | 101,763 | 96,426 | 85,817 | 73,730 | 68,885 | 66,928 |
研發費用 | 24,166 | 18,753 | 19,325 | 35,215 | 26,057 | 24,017 | 26,334 | 20,052 | 17,106 | 23,767 |
推銷及管理費用 | 112,411 | 99,281 | 87,320 | 88,724 | 75,706 | 72,409 | 59,483 | 53,678 | 51,779 | 43,161 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 24,021 | 20,160 | 13,272 | -19,299 | -9,658 | -117 | -16,542 | 81 | -10,927 | -3,154 |
其他收入及費用 | 3,136 | 2,717 | 2,293 | 2,320 | 2,457 | 2,421 | 2,266 | 2,369 | 2,428 | 1,915 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 27,157 | 22,877 | 15,565 | -16,979 | -7,201 | 2,304 | -14,276 | 2,450 | -8,499 | -1,239 |
所得稅 | 8,722 | 5,045 | 7,026 | -8,091 | 5,492 | 6,212 | 3,428 | -22,787 | 5,356 | -16,211 |
稅後純益 | 18,435 | 17,832 | 8,539 | -8,888 | -12,693 | -3,908 | -17,704 | 25,237 | -13,855 | 14,972 |
基本每股稅後盈餘(元) | 0.25 | 0.24 | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 | -0.20 | 0.21 |
稀釋每股稅後盈餘(元) | 0.23 | 0.23 | 0.11 | -0.12 | -0.17 | -0.06 | -0.25 | 0.36 | -0.20 | 0.22 |
基本平均股數(千股) | 74714.00 | 73438.00 | 72647.00 | 72319.00 | 71726.00 | 71004.00 | 70633.00 | 70371.00 | 70186.00 | 69918.00 |
稀釋平均股數(千股) | 80035.00 | 77942.00 | 76145.00 | 72319.00 | 71726.00 | 71004.00 | 70633.00 | 72660.00 | 70186.00 | 71634.00 |
還原基本每股稅後盈餘(元) | 0.25 | 0.24 | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 | 0.36 | -0.20 | 0.21 |
還原稀釋每股稅後盈餘(元) | 0.23 | 0.23 | 0.11 | -0.12 | -0.17 | -0.06 | -0.25 | 0.36 | -0.20 | 0.22 |
還原基本平均股數(千股) | 74,714 | 73,438 | 72,647 | 72,319 | 71,726 | 71,004 | 70,633 | 70,371 | 70,186 | 69,918 |
還原稀釋平均股數(千股) | 80,035 | 77,942 | 76,145 | 72,319 | 71,726 | 71,004 | 70,633 | 72,660 | 70,186 | 71,634 |
EBITDA(千元) | 28,144 | 22,391 | 16,165 | -15,760 | -7,289 | 2,546 | -13,513 | 2,694 | -6,455 | -1,789 |